Cyanobacteria, among Earth's oldest organisms, have evolved sophisticated biosynthetic pathways to produce a rich arsenal of bioactive natural products. In consequence, cyanobacterial secondary metabolites have been an incredibly fruitful source of lead compounds in drug discovery efforts. Investigations into the biochemistry responsible for the creation of these compounds, complemented by genome sequencing efforts, are revealing unique enzymatic mechanisms not described or rarely described elsewhere in the natural world. Herein, we discuss recent advances in understanding the biosynthesis of three cyanobacterial classes of natural product: mixed polyketide synthase/non ribosomal peptide synthetase (PKS/NRPS) metabolites, aromatic amino acid-derived alkaloids, and ribosomally encoded cyclic peptides. The unique biosynthetic mechanisms employed by cyanobacteria are inspiring new developments in heterologous gene expression and biotechnology.
Cyanobacteria, among Earth's oldest organisms, have evolved sophisticated biosynthetic pathways to produce a rich arsenal of bioactive natural products. In consequence, cyanobacterial secondary metabolites have been an incredibly fruitful source of lead compounds in drug discovery efforts. Investigations into the biochemistry responsible for the creation of these compounds, complemented by genome sequencing efforts, are revealing unique enzymatic mechanisms not described or rarely described elsewhere in the natural world. Herein, we discuss recent advances in understanding the biosynthesis of three cyanobacterial classes of natural product: mixed polyketide synthase/non ribosomal peptide synthetase (PKS/NRPS) metabolites, n class="Chemical">aromatic amino acid-derived alkaloids, and ribosomally encoded cyclic peptides. The unique biosynthetic mechanisms employed by cyanobacteria are inspiring new developments in heterologous gene expression and biotechnology.
Authors: Zunxue Chang; Namthip Sitachitta; James V Rossi; Mary Ann Roberts; Patricia M Flatt; Junyong Jia; David H Sherman; William H Gerwick Journal: J Nat Prod Date: 2004-08 Impact factor: 4.050
Authors: Daniel J Edwards; Brian L Marquez; Lisa M Nogle; Kerry McPhail; Douglas E Goeger; Mary Ann Roberts; William H Gerwick Journal: Chem Biol Date: 2004-06
Authors: Sara Jonasson; Johan Eriksson; Lotta Berntzon; Zdenek Spácil; Leopold L Ilag; Lars-Olof Ronnevi; Ulla Rasmussen; Birgitta Bergman Journal: Proc Natl Acad Sci U S A Date: 2010-05-03 Impact factor: 11.205
Authors: Hyukjae Choi; Alban R Pereira; Zhengyu Cao; Cynthia F Shuman; Niclas Engene; Tara Byrum; Teatulohi Matainaho; Thomas F Murray; Alfonso Mangoni; William H Gerwick Journal: J Nat Prod Date: 2010-08-27 Impact factor: 4.050
Authors: Jacob R Winnikoff; Evgenia Glukhov; Jeramie Watrous; Pieter C Dorrestein; William H Gerwick Journal: J Antibiot (Tokyo) Date: 2013-11-27 Impact factor: 2.649
Authors: Nathan A Moss; Matthew J Bertin; Karin Kleigrewe; Tiago F Leão; Lena Gerwick; William H Gerwick Journal: J Ind Microbiol Biotechnol Date: 2015-11-17 Impact factor: 3.346
Authors: Carla J S Barber; Pareshkumar T Pujara; Darwin W Reed; Shiela Chiwocha; Haixia Zhang; Patrick S Covello Journal: J Biol Chem Date: 2013-03-13 Impact factor: 5.157